Herceptin Regimen Minus Adriamycin Increases Survival With Less Toxicity
Alimta Reduces Risk Of Progression In Patients Aged 70 Years or Older
Family History of BRCA Mutation Does Not Equal Increased Risk
Daily Vitamin E Supplements Can Lead to Increased PCa Risk
Digital Immunoassay PSA Test May Predict Cancer Recurrence
Talactoferrin Second-Line Therapy Increases Survival In Stage IIIB/IV
Researchers Discover Bacteria Common in Colon Cancer Tissue
Colon Cancer Survival Rates Differ Across Racial Lines
NCI Predicts 42 Percent Increase In Number of Senior Survivors
IMRT Less Toxic Than 3D-CRT In Localized Prostate Cancer
NCI CTEP: Approved Trials For The Month of October
FDA Grants Accelerated Approval To Ferriprox for Iron Overload
Trending Stories
- NIH Director Jay Bhattacharya launches a podcast
- As Trump decimates NIH funding, a daring proposal to issue $750 billion in bonds for medical cures garners attention
- Lou Weisbach tells us about his plan to raise $750 billion for the American Center for Cures
- “Forward funding” NIH budget plan would make competing for grants much harder
- Optimizing dosing of expensive and toxic oncology drugs: Making America healthier
- The Directors: Tom Lynch and Skip Burris on how NIH funding cuts imperil biopharma innovation—and cost patient lives
In a time of uncertainty, “react to the knowns, not the fear”
